Corrigendum to "Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial": Annals of Oncology 2012; 23: 1818-1825.

Autor: Behringer K; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Thielen I; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Mueller H; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Goergen H; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Eibl AD; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Rosenbrock J; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Halbsguth T; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Eichenauer DA; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Fuchs M; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Reiners KS; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Renno JH; Institute for Clinical Chemistry, University of Cologne, Cologne, Germany., van der Ven K; Department of Gynecological Endocrinology and Reproductive Medicine, University of Bonn, Bonn, Germany., Kuehr M; Department of Gynecological Endocrinology and Reproductive Medicine, University of Bonn, Bonn, Germany., von Wolff M; Department of Gynecological Endocrinology and Reproductive Medicine, University Women's Hospital, Bern, Switzerland., Diehl V; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Engert A; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany., Borchmann P; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany. Electronic address: peter.borchmann@uni-koeln.de.
Jazyk: angličtina
Zdroj: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Aug; Vol. 31 (8), pp. 1093. Date of Electronic Publication: 2020 Jun 15.
DOI: 10.1016/j.annonc.2020.05.020
Databáze: MEDLINE